Seattle Inno picks 22 startups to watch in 2022
Amidst several mergers, acquisitions and funding rounds in the last year, Seattle Inno has named 22 startups to watch in 2022, including Mozart Therapeutics. The Seattle-based biotech raised $55 million in October.
Katie Fanning, CEO of Mozart Therapeutics said she aims to improve treatment of autoimmune and inflammatory diseases the same way the famous composer changed music.